Let’s even make it 30 days earlier for ezetimibe generics
Although a hyperlipidemia treatment substance, ‘ezetimibe,’ is about to be expired in patent, a series of domestic companies have filed trials to avoid the patent. The phenomenon is interpreted as their will to launch products even a month or two months earlier.
The ezetimibe’s patent will be ex...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
